Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Search

Page Path
HOME > Search
5 "Vishal Sharma"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Articles
IBD
Sarcopenia is common in ulcerative colitis and correlates with disease activity
Pardhu B Neelam, Rimesh Pal, Pankaj Gupta, Anupam K Singh, Jimil Shah, Harshal S Mandavdhare, Harjeet Singh, Aravind Sekar, Sanjay K Bhadada, Usha Dutta, Vishal Sharma
Intest Res 2024;22(2):162-171.   Published online January 22, 2024
DOI: https://doi.org/10.5217/ir.2023.00090
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Background/Aims
Association of sarcopenia with disease severity in ulcerative colitis (UC) is not clearly defined. We planned to estimate the prevalence of sarcopenia in patients with UC as per the revised definition and its relation with the disease severity.
Methods
A cross-sectional assessment of sarcopenia in patients with UC was performed. Disease activity was graded according to complete Mayo score. Hand grip strength was assessed with Jamar hand dynamometer, muscle mass using a dual energy X-ray absorptiometry scan, and physical performance with 4-m walk test. Sarcopenia was defined as a reduction of both muscle mass and strength. Severe sarcopenia was defined as reduced gait speed in presence of sarcopenia.
Results
Of 114 patients (62 males, mean age: 36.49±12.41 years), 32 (28%) were in remission, 46 (40.4%) had mild-moderate activity, and 36 (31.6%) had severe UC. Forty-three patients (37.7%) had probable sarcopenia, 25 (21.9%) had sarcopenia, and 14 (12.2%) had severe sarcopenia. Prevalence of sarcopenia was higher in active disease (2 in remission, 6 in active, and 17 in severe, P<0.001). Of 14 with severe sarcopenia, 13 had severe UC while 1 had moderate UC. On multivariate analysis, lower body mass index and higher Mayo score were associated with sarcopenia. Of 37 patients with acute severe colitis, 16 had sarcopenia. Requirement of second-line therapy was similar between patients with and without sarcopenia. On follow-up (median: 18 months), there was a non-significant higher rate of major adverse events in those with sarcopenia (47.4% vs. 33.8%, P=0.273).
Conclusions
Sarcopenia and severe sarcopenia in UC correlate with the disease activity.

Citations

Citations to this article as recorded by  
  • Sarcopenia and frailty in inflammatory bowel disease: Emerging concepts and evidence
    Pardhu B Neelam, Alka Sharma, Vishal Sharma
    JGH Open.2024;[Epub]     CrossRef
  • Utility of SARC‐F for screening for sarcopenia in ulcerative colitis
    Pardhu B. Neelam, Vishal Sharma
    Nutrition in Clinical Practice.2024; 39(5): 1270.     CrossRef
  • Response to “Utility of SARC‐F for screening for sarcopenia in ulcerative colitis”
    Ilkay Ergenc, Chasan Ismail Basa, Alper Uzum, Sevval Sahin, Haluk Tarık Kani, Rahmi Aslan, Aslı Tufan, Özgür Kasımay, Özlen Atuğ, Yeşim Özen Alahdab
    Nutrition in Clinical Practice.2024; 39(5): 1272.     CrossRef
  • 4,039 View
  • 257 Download
  • 3 Web of Science
  • 3 Crossref
Close layer
IBD
Clinical presentation of COVID-19 in patients with inflammatory bowel disease: a systematic review and meta-analysis
Anupam K. Singh, Anuraag Jena, Praveen Kumar-M, Daya Krishna Jha, Vishal Sharma
Intest Res 2022;20(1):134-143.   Published online January 18, 2021
DOI: https://doi.org/10.5217/ir.2020.00108
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Background/Aims
Coronavirus disease 2019 (COVID-19) is recognized to have variable clinical manifestations. The clinical presentation of patients with inflammatory bowel disease (IBD) having COVID-19 is unclear.
Methods
We identified articles reporting about the clinical presentation of COVID-19 in those with underlying IBD from PubMed and Embase. The studies, irrespective of design or language, were included. The overall pooled frequency of various symptoms was estimated. Joanna Briggs Institute Critical appraisal checklist was used to assess the quality of studies.
Results
Eleven studies, including 1,325 patients, were included in the pooled analysis. The pooled estimates for clinical presentation were; fever: 67.53% (95% confidence interval [CI], 45.38–83.88), cough: 59.58% (95% CI, 45.01–72.63), diarrhea: 27.26% (95% CI, 19.51–36.69), running nose: 27% (95% CI, 15.26–43.19) and dyspnea: 25.29% (95% CI, 18.52–33.52). The pooled prevalence rates for abdominal pain, nausea and vomiting were 13.08% (95% CI, 9.24–18.19), 10.08% (95% CI, 5.84–16.85) and 8.80% (95% CI, 4.43–16.70) per 100 population, respectively.
Conclusions
The clinical presentation of COVID-19 in IBD patients is similar to the general population.

Citations

Citations to this article as recorded by  
  • Small Bowel Diverticulosis and COVID-19: Awareness Is the Key: A Case Series and Review of the Literature
    Petros Bangeas, Nikolaos Konstantinidis, Tania Chrisopoulou, Despoina Karatzia, Alexandros Giakoustidis, Vasileios Papadopoulos
    Medicina.2024; 60(2): 229.     CrossRef
  • Exacerbated gastrointestinal symptoms and long COVID in IBD patients with SARS-CoV-2 infection: A multi-center study from taiwan
    Tsung-Yu Tsai, Jia-Feng Wu, Meng-Tzu Weng, Chiao-Hsiung Chuang, Tien-Yu Huang, Wei-Chen Tai, Chi-Ming Tai, Chen-Shuan Chung, Chih-Cheng Chen, Ching-Pin Lin, Yuan-Yao Tsai, Shu-Chen Wei
    Journal of the Formosan Medical Association.2024; 123(8): 866.     CrossRef
  • COVID-19 IN INFLAMMATORY BOWEL DISEASE: SHOULD WE BE MORE CAREFUL WITH THE USE OF SALICYLATES?
    Mariana Rolim Fernandes MACEDO, Carlos Arthur Fernandes SOBREIRA, Carola Braz de LAVOR, Camila Ribeiro RÔLA, Ticiana Maria de Lavor ROLIM, Francisco Sérgio Rangel de Paula PESSOA, Milena Santana GIRÃO, Caio César Furtado FREIRE, Ranna Caroline Bezerra SIE
    Arquivos de Gastroenterologia.2024;[Epub]     CrossRef
  • Diarrhea and Coronavirus Disease 2019 Infection
    David M. Friedel, Mitchell S. Cappell
    Gastroenterology Clinics of North America.2023; 52(1): 59.     CrossRef
  • Managing IBD in the COVID-19 era
    Nicholas Scalzo, Ryan C. Ungaro
    Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
  • Impact of COVID-19 in individuals with and without pre-existent digestive disorders with a particular focus on elderly patients
    Alfredo Papa, Marcello Covino, Sara Sofia De Lucia, Angelo Del Gaudio, Marcello Fiorani, Giorgia Polito, Carlo Romano Settanni, Andrea Piccioni, Francesco Franceschi, Antonio Gasbarrini
    World Journal of Gastroenterology.2023; 29(26): 4099.     CrossRef
  • Twelve Months with COVID-19: What Gastroenterologists Need to Know
    Giulia Concas, Michele Barone, Ruggiero Francavilla, Fernanda Cristofori, Vanessa Nadia Dargenio, Rossella Giorgio, Costantino Dargenio, Vassilios Fanos, Maria Antonietta Marcialis
    Digestive Diseases and Sciences.2022; 67(7): 2771.     CrossRef
  • Perceptions and Behaviors of Patients with Inflammatory Bowel Disease during the COVID-19 Crisis
    Yoo Jin Lee, Kyeong Ok Kim, Min Cheol Kim, Kwang Bum Cho, Kyung Sik Park, Byeong Ik Jang
    Gut and Liver.2022; 16(1): 81.     CrossRef
  • Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic
    Simeng Lin, Louis HS Lau, Neil Chanchlani, Nicholas A Kennedy, Siew C Ng
    Gut.2022; 71(7): 1426.     CrossRef
  • Vaccination strategies for Korean patients with inflammatory bowel disease
    Yoo Jin Lee, Eun Soo Kim
    The Korean Journal of Internal Medicine.2022; 37(5): 920.     CrossRef
  • Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements
    Yong Eun Park, Yoo Jin Lee, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seong-Eun Kim, Seung-Jae Myung
    Intestinal Research.2022; 20(4): 431.     CrossRef
  • Endoscopy within 7 days after detecting high calprotectin levels can be useful for therapeutic decision-making in ulcerative colitis
    Ho Min Yong, Sung-Jo Park, Seong Ran Jeon, Heesu Park, Hyun Gun Kim, Tae Hee Lee, Junseok Park, Jin-Oh Kim, Joon Seong Lee, Bong Min Ko, Hyeon Jeong Goong, Suyeon Park
    Medicine.2021; 100(34): e27065.     CrossRef
  • KASID Guidance for Clinical Practice Management of Adult Inflammatory Bowel Disease during the COVID-19 Pandemic: Expert Consensus Statement
    Yong Eun Park, Yoo Jin Lee, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seong-Eun Kim, Seung-Jae Myung
    The Korean Journal of Gastroenterology.2021; 78(2): 105.     CrossRef
  • The natural history of COVID-19 in patients with inflammatory bowel disease: a nationwide study by the Hellenic Society for the study of IBD
    Giorgos Bamias, Georgios Kokkotis, Angeliki Christidou, Dimitrios K. Christodoulou, Vasileios Delis, Georgia Diamantopoulou, Smaragdi Fessatou, Anthia Gatopoulou, Olga Giouleme, Panagiota Kafritsa, Chrisostomos Kalantzis, Andreas Kapsoritakis, Pantelis Ka
    European Journal of Gastroenterology & Hepatology.2021; 33(1S): e810.     CrossRef
  • 6,683 View
  • 429 Download
  • 14 Web of Science
  • 14 Crossref
Close layer
Brief Communication
Infection
Gastrointestinal histoplasmosis: a case series from a non-endemic region in North India
Harshal S Mandavdhare, Jimil Shah, Kaushal K Prasad, Roshan Agarwala, Vikas Suri, Savita Kumari, Usha Dutta, Vishal Sharma
Intest Res 2019;17(1):149-152.   Published online October 16, 2018
DOI: https://doi.org/10.5217/ir.2018.00111
PDFPubReaderePub

Citations

Citations to this article as recorded by  
  • Gastrointestinal Histoplasmosis: A Descriptive Review, 2001–2021
    Bassey E. Ekeng, Asa E. Itam-Eyo, Iriagbonse I. Osaigbovo, Adilia Warris, Rita O. Oladele, Felix Bongomin, David W. Denning
    Life.2023; 13(3): 689.     CrossRef
  • Isolated Colonic Histoplasmosis in Patients Undergoing Immunomodulator Therapy: A Systematic Review
    Faisal Inayat, Gul Nawaz, Arslan Afzal, Maleeha Ajmal, Marjan Haider, Muhammad Sarfraz, Zaka Ul Haq, Sobaan Taj, Rizwan Ishtiaq
    Journal of Investigative Medicine High Impact Case Reports.2023; 11: 232470962311794.     CrossRef
  • An Unusual Discovery of Multi-Opportunistic Organisms in Gastrointestinal Biopsies of a Patient With Acquired Immunodeficiency Syndrome and Infectious Colitis
    Chirag Patel, Patricia Le, Malik Salman, Stephen Cavalieri, Joyce Kovar
    Cureus.2023;[Epub]     CrossRef
  • A case report of gastrointestinal histoplasmosis in a patient treated with infliximab
    Berta Oliveras, Marc Albert, Carme López, Esther Fort, Laia Peries, Laia Gutiérrez, David Busquets, Hugo Uchima, Xavier Aldeguer, Virginia Piñol
    Clinical Journal of Gastroenterology.2021; 14(2): 690.     CrossRef
  • A case of gastrointestinal histoplasmosis with esophageal involvement
    Mathew Finniss, Paul Lewis, James Myers, Lamis Ibrahim, Paras Patel
    Clinical Journal of Gastroenterology.2020; 13(2): 173.     CrossRef
  • Ileocecal thickening: Clinical approach to a common problem
    Roshan Agarwala, Abhi K Singh, Jimil Shah, Harshal S Mandavdhare, Vishal Sharma
    JGH Open.2019; 3(6): 456.     CrossRef
  • 8,177 View
  • 182 Download
  • 6 Web of Science
  • 6 Crossref
Close layer
Case Report
Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers
Harshal Surendra Mandavdhare, Vishal Sharma, Kaushal K Prasad, Amit Kumar, Manish Rathi, Surinder S Rana
Intest Res 2017;15(3):419-421.   Published online June 12, 2017
DOI: https://doi.org/10.5217/ir.2017.15.3.419
AbstractAbstract PDFPubReaderePub

Recent studies have identified sprue-like illness associated with the use of the antihypertensive agent olmesartan medoxomil. However, whether this condition is specific to the use of olmesartan or is associated with the use of drugs belonging to the class of “sartans” remains to be clarified. A 45-year-old woman with chronic kidney disease along with hypothyroidism and hypertension presented with chronic diarrhea and significant weight loss. Endoscopy of the upper gastrointestinal tract showed scalloping and grooving of the duodenum, and histopathological examination showed subtotal villous atrophy. She was on telmisartan for hypertension, which was discontinued. Subsequently, diarrhea ameliorated dramatically, and she regained weight. To our knowledge, this is the first study to report telmisartan-associated sprue-like enteropathy. Further, we have reviewed the cases of patients with sprue-like enteropathy caused by valsartan, irbesartan, and eprosartan.

Citations

Citations to this article as recorded by  
  • Olmesartan induced gastritis and enteropathy
    Ankur Gupta, Priyanka Jain, Latika Gupta
    Indian Journal of Gastroenterology.2024; 43(3): 684.     CrossRef
  • Systematic review: Clinical phenotypes, histopathological features and prognosis of enteropathy due to angiotensin II receptor blockers
    Annalisa Schiepatti, Paolo Minerba, Michele Puricelli, Stiliano Maimaris, Giovanni Arpa, Federico Biagi, David S. Sanders
    Alimentary Pharmacology & Therapeutics.2024; 59(4): 432.     CrossRef
  • Olmesartan induced enteropathy affecting the entire gastrointestinal tract: a case report
    N Van Horebeek, R Croes, A Vonck, E Colpaert
    Acta Gastro Enterologica Belgica.2023; 86(1): 95.     CrossRef
  • A Case of Sprue-like Enteropathy Associated With Valsartan and Irbesartan
    Seo Yeon Yoo, Jihun Kim, Kee Wook Jung
    Journal of Neurogastroenterology and Motility.2022; 28(2): 327.     CrossRef
  • The histological spectrum of ARB‐induced gastritis
    Tanner Storozuk, Ian Brown, Stephen Lagana, Maria Westerhoff, Namrata Setia, John Hart, Lindsay Alpert
    Histopathology.2022; 81(5): 653.     CrossRef
  • Severe cases of sprue‐like enteropathy associated with angiotensin receptor blockers other than olmesartan
    Peter Malfertheiner, Chiara Formigoni
    GastroHep.2021; 3(2): 88.     CrossRef
  • Telmisartan-induced sprue-like enteropathy: a case report
    Natalia Alzueta, Amaya Echeverría, Lorea Sanz, Carmen Fontela, Teresa Acín, Lidia Montenegro, Javier Garjón
    European Journal of Hospital Pharmacy.2020; 27(1): 49.     CrossRef
  • Olmesartan Associated Enteropathy: Usefulness of Video Capsule Endoscopy in a Case With Doubtful Upper Endoscopic/Histological Picture
    Francesco Abbruzzi, Ilaria Loconte, Sonia Carparelli, Enzo Ierardi, Alfredo Di Leo, Mariabeatrice Principi
    Current Drug Safety.2020; 15(1): 65.     CrossRef
  • Traitement par olmésartan et entéropathie : à propos de deux cas et revue de la littérature
    A. Sadki, M. Le Besnerais, F. Héron, I. Marie
    La Revue de Médecine Interne.2019; 40(2): 112.     CrossRef
  • A simple treatment for a potentially life-threatening cause of malabsorption
    Mattia Bonzi, Elisa M. Fiorelli, Gaia Montanelli, Ludovico Furlan, Monica Solbiati
    Internal and Emergency Medicine.2019; 14(6): 967.     CrossRef
  • Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review
    Ayesha Kamal, Christopher Fain, Angela Park, Peiqi Wang, Eduardo Gonzalez-Velez, Daniel A Leffler, Susan M Hutfless
    Gastroenterology Report.2019; 7(3): 162.     CrossRef
  • Association of sprue-like enteropathy and angiotensin receptor-1 antagonists
    René R. Wenzel, Christian Datz
    Wiener klinische Wochenschrift.2019; 131(19-20): 493.     CrossRef
  • Severe intestinal malabsorption associated with ACE inhibitor or angiotensin receptor blocker treatment. An observational cohort study in Germany and Italy
    Peter Malfertheiner, Claudio Ripellino, Nazarena Cataldo
    Pharmacoepidemiology and Drug Safety.2018; 27(6): 581.     CrossRef
  • 5,913 View
  • 89 Download
  • 14 Web of Science
  • 13 Crossref
Close layer
Systematic Review
Accuracy of computed tomographic features in differentiating intestinal tuberculosis from Crohn's disease: a systematic review with meta-analysis
Saurabh Kedia, Raju Sharma, Vishnubhatla Sreenivas, Kumble Seetharama Madhusudhan, Vishal Sharma, Sawan Bopanna, Venigalla Pratap Mouli, Rajan Dhingra, Dawesh Prakash Yadav, Govind Makharia, Vineet Ahuja
Intest Res 2017;15(2):149-159.   Published online April 27, 2017
DOI: https://doi.org/10.5217/ir.2017.15.2.149
AbstractAbstract PDFPubReaderePub

Abdominal computed tomography (CT) can noninvasively image the entire gastrointestinal tract and assess extraintestinal features that are important in differentiating Crohn's disease (CD) and intestinal tuberculosis (ITB). The present meta-analysis pooled the results of all studies on the role of CT abdomen in differentiating between CD and ITB. We searched PubMed and Embase for all publications in English that analyzed the features differentiating between CD and ITB on abdominal CT. The features included comb sign, necrotic lymph nodes, asymmetric bowel wall thickening, skip lesions, fibrofatty proliferation, mural stratification, ileocaecal area, long segment, and left colonic involvements. Sensitivity, specificity, positive and negative likelihood ratios, and diagnostic odds ratio (DOR) were calculated for all the features. Symmetric receiver operating characteristic curve was plotted for features present in >3 studies. Heterogeneity and publication bias was assessed and sensitivity analysis was performed by excluding studies that compared features on conventional abdominal CT instead of CT enterography (CTE). We included 6 studies (4 CTE, 1 conventional abdominal CT, and 1 CTE+conventional abdominal CT) involving 417 and 195 patients with CD and ITB, respectively. Necrotic lymph nodes had the highest diagnostic accuracy (sensitivity, 23%; specificity, 100%; DOR, 30.2) for ITB diagnosis, and comb sign (sensitivity, 82%; specificity, 81%; DOR, 21.5) followed by skip lesions (sensitivity, 86%; specificity, 74%; DOR, 16.5) had the highest diagnostic accuracy for CD diagnosis. On sensitivity analysis, the diagnostic accuracy of other features excluding asymmetric bowel wall thickening remained similar. Necrotic lymph nodes and comb sign on abdominal CT had the best diagnostic accuracy in differentiating CD and ITB.

Citations

Citations to this article as recorded by  
  • Differentiation of Crohn's disease, ulcerative colitis, and intestinal tuberculosis by dual-layer spectral detector CT enterography
    M. Huang, L. Tu, J. Li, X. Yue, L. Wu, M. Yang, Y. Chen, P. Han, X. Li, L. Zhu
    Clinical Radiology.2024; 79(3): e482.     CrossRef
  • Deep Learning Radiomics Analysis of CT Imaging for Differentiating Between Crohn’s Disease and Intestinal Tuberculosis
    Ming Cheng, Hanyue Zhang, Wenpeng Huang, Fei Li, Jianbo Gao
    Journal of Imaging Informatics in Medicine.2024; 37(4): 1516.     CrossRef
  • New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis
    Himanshu Narang, Saurabh Kedia, Vineet Ahuja
    Current Opinion in Infectious Diseases.2024; 37(5): 392.     CrossRef
  • Management and monitoring of pediatric inflammatory bowel disease in the Asia‐Pacific region: A position paper by the Asian Pan‐Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition (APPSPGHAN) PIBD Working Group: Surgical management,
    Way Seah Lee, Katsuhiro Arai, George Alex, Suporn Treepongkaruna, Kyung Mo Kim, Chee Liang Choong, Karen Calixto Mercado, Andy Darma, Anshu Srivastava, Marion M. Aw
    Journal of Gastroenterology and Hepatology.2023; 38(4): 510.     CrossRef
  • Granulomatous bowel disease: Crohn’s disease and tuberculosis. Difficulties in differential diagnosis (case report and review)
    A. V. Vardanyan, E. S. Merkulova, V. A. Belinskaya, K. S. Frolova, O. A. Mainovskaya
    Koloproktologia.2023; 22(1): 117.     CrossRef
  • Evidence-based approach to diagnosis and management of abdominal tuberculosis
    Daya Krishna Jha, Mythili Menon Pathiyil, Vishal Sharma
    Indian Journal of Gastroenterology.2023; 42(1): 17.     CrossRef
  • Differentiating gastrointestinal tuberculosis and Crohn's disease- a comprehensive review
    Arup Choudhury, Jasdeep Dhillon, Aravind Sekar, Pankaj Gupta, Harjeet Singh, Vishal Sharma
    BMC Gastroenterology.2023;[Epub]     CrossRef
  • Recent updates in diagnosis of abdominal tuberculosis with emphasis on nucleic acid amplification tests
    Preeti Mor, Bhawna Dahiya, Sanjeev Parshad, Pooja Gulati, Promod K. Mehta
    Expert Review of Gastroenterology & Hepatology.2022; 16(1): 33.     CrossRef
  • Addition of computed tomography chest increases the diagnosis rate in patients with suspected intestinal tuberculosis
    Saurabh Kedia, Raju Sharma, Sudheer Kumar Vuyyuru, Deepak Madhu, Pabitra Sahu, Bhaskar Kante, Prasenjit Das, Ankur Goyal, Karan Madan, Govind Makharia, Vineet Ahuja
    Intestinal Research.2022; 20(2): 184.     CrossRef
  • Systematic reporting of computed tomography enterography/enteroclysis as an aid to reduce diagnostic dilemma when differentiating between intestinal tuberculosis and Crohn's disease: A prospective study at a tertiary care hospital
    Amrin Israrahmed, Rajanikant R Yadav, Geeta Yadav, Alpana, Rajesh V Helavar, Praveer Rai, Manoj Kumar Jain, Archna Gupta
    JGH Open.2021; 5(2): 180.     CrossRef
  • Intestinal Tuberculosis: A Diagnostic Challenge
    Hansang Park, Tikal Kansara, Ana M Victoria, Noella Boma, Jungrak Hong
    Cureus.2021;[Epub]     CrossRef
  • Intestinal tuberculosis or Crohn's disease: Illusion or delusion or allusion
    Saurabh Kedia, Vineet Ahuja
    JGH Open.2021; 5(2): 177.     CrossRef
  • Deep‐learning system for real‐time differentiation between Crohn's disease, intestinal Behçet's disease, and intestinal tuberculosis
    Jung Min Kim, Jun Gu Kang, Sungwon Kim, Jae Hee Cheon
    Journal of Gastroenterology and Hepatology.2021; 36(8): 2141.     CrossRef
  • Prospective validation of CD4+CD25+FOXP3+ T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn’s disease
    Ritika Rampal, Saurabh Kedia, Mohamad Nahidul Wari, Deepak Madhu, Amit Kumar Singh, Veena Tiwari, V. Pratap Mouli, Srikant Mohta, Govind Makharia, Vineet Ahuja
    Intestinal Research.2021; 19(2): 232.     CrossRef
  • Correlation-driven framework based on graph convolutional network for clinical disease classification
    Kai Cao, Ying Xiao, Muzhou Hou
    Journal of Statistical Computation and Simulation.2021; 91(15): 3108.     CrossRef
  • Difficulties in the differential diagnosis of intestinal tuberculosis and Crohn‘s disease
    M. N. Reshetnikov, D. V. Plotkin, Yu. R. Zyuzya, A. A. Volkov, O. N. Zuban, E. M. Bogorodskaya
    Acta Biomedica Scientifica.2021; 6(5): 196.     CrossRef
  • Diagnostic performance of CT for differentiating peritoneal tuberculosis from peritoneal carcinomatosis: a systematic review and meta-analysis
    J. Chen, S. Liu, Y. Tang, X. Zhang, M. Cao, Z. Xiao, M. Ren, T. Chen
    Clinical Radiology.2020; 75(5): 396.e7.     CrossRef
  • Disseminated tuberculosis presenting as massive lower gastrointestinal bleeding
    Nehal Aggarwal, SubodhKumar Mahto, Akanskha Singh, Kritika Gupta, Ankita Aneja, Anu Singh, Atul Goel
    Journal of Family Medicine and Primary Care.2020; 9(2): 1226.     CrossRef
  • Differentiating Crohn’s disease from intestinal tuberculosis
    Saurabh Kedia, Prasenjit Das, Kumble Seetharama Madhusudhan, Siddhartha Dattagupta, Raju Sharma, Peush Sahni, Govind Makharia, Vineet Ahuja
    World Journal of Gastroenterology.2019; 25(4): 418.     CrossRef
  • The potential role of CT enterography and gastrointestinal ultrasound in the evaluation of anti-tubercular therapy response of intestinal tuberculosis: a retrospective study
    Li Ma, Qingli Zhu, Yue Li, Wenbo Li, Xuan Wang, Wei Liu, Jianchu Li, Yuxin Jiang
    BMC Gastroenterology.2019;[Epub]     CrossRef
  • Indian guidelines on imaging of the small intestine in Crohn’s disease: A joint Indian Society of Gastroenterology and Indian Radiology and Imaging Association consensus statement
    Saurabh Kedia, Raju Sharma, Govind Makharia, Vineet Ahuja, Devendra Desai, Devasenathipathy Kandasamy, Anu Eapen, Karthik Ganesan, Uday C Ghosha, Naveen Kalra, R Karthikeyan, Kumble Seetharama Madhusudhan, Mathew Philip, Amarender Puri, Sunil Puri, Saroj
    Indian Journal of Radiology and Imaging.2019; 29(02): 111.     CrossRef
  • Imaging in discriminating intestinal tuberculosis and Crohn’s disease: past, present and the future
    Pradeep Goyal, Jimil Shah, Sonali Gupta, Pankaj Gupta, Vishal Sharma
    Expert Review of Gastroenterology & Hepatology.2019; 13(10): 995.     CrossRef
  • Combination of increased visceral fat and long segment involvement: Development and validation of an updated imaging marker for differentiating Crohn's disease from intestinal tuberculosis
    Saurabh Kedia, Kumble S Madhusudhan, Raju Sharma, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Saransh Jain, Prasenjit Das, Siddhartha Dattagupta, Govind Makharia, Vineet Ahuja
    Journal of Gastroenterology and Hepatology.2018; 33(6): 1234.     CrossRef
  • Computed Tomography Enterography: Quantitative Evaluation on Crohn’s Disease Activity
    Jingyun Cheng, Hui Xie, Hao Yang, Ke Wang, Guobin Xu, Guangyao Wu
    Gastroenterology Research and Practice.2018; 2018: 1.     CrossRef
  • Gastrointestinal Tuberculosis Presenting as Malnutrition and Distal Colonic Bowel Obstruction
    Raja Chandra Chakinala, Zahava C. Farkas, Benjamin Barbash, Khwaja F. Haq, Shantanu Solanki, Muhammad Ali Khan, Edward Esses, Taliya Farooq, Brad Dworkin
    Case Reports in Gastrointestinal Medicine.2018; 2018: 1.     CrossRef
  • Diagnostic point-of-care ultrasound (POCUS) for gastrointestinal pathology: state of the art from basics to advanced
    Fikri M Abu-Zidan, Arif Alper Cevik
    World Journal of Emergency Surgery.2018;[Epub]     CrossRef
  • Enfermedad de Crohn vs tuberculosis intestinal: un diagnóstico diferencial desafiante. Revisión de tema
    Gabriel Alonso Mosquera-Klinger, Andrea Ucroz Benavides
    Revista Colombiana de Gastroenterología.2018; 33(4): 423.     CrossRef
  • Imaging of the small intestine in Crohn’s disease: Joint position statement of the Indian Society of Gastroenterology and Indian Radiological and Imaging Association
    Saurabh Kedia, Raju Sharma, Govind K. Makharia, Vineet Ahuja, Devendra Desai, Devasenathipathy Kandasamy, Anu Eapen, Karthik Ganesan, Uday C. Ghoshal, Naveen Kalra, D. Karthikeyan, Kumble Seetharama Madhusudhan, Mathew Philip, Amarender Singh Puri, Sunil
    Indian Journal of Gastroenterology.2017; 36(6): 487.     CrossRef
  • Editor’s Pick: Recent Advances in the Diagnosis and Management of Abdominal Tuberculosis
    Harshal S. Mandavdhare, Harjeet Singh, Vishal Sharma
    EMJ Gastroenterology.2017; : 52.     CrossRef
  • 8,112 View
  • 137 Download
  • 27 Web of Science
  • 29 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP